Today: 29 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Nvidia stock up early after Reuters report on China H200 approvals, with Fed decision ahead

Nvidia stock up early after Reuters report on China H200 approvals, with Fed decision ahead

Nvidia shares rose 1.1% to $188.52 early Wednesday after China approved ByteDance, Alibaba, and Tencent to buy over 400,000 H200 AI chips, Reuters reported. The approvals come with strict conditions, and some sources say licenses remain too restrictive for orders. Chip stocks rallied broadly, with Broadcom up 2.4% and the VanEck Semiconductor ETF up 2.1%. Investors await the Federal Reserve decision and megacap tech earnings later today.
28 January 2026
·····
Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Why Gilead stock hit a fresh 52-week high as Medicare targets Biktarvy and earnings loom

Gilead Sciences shares rose 2.3% to $140.97 Tuesday, hitting a 52-week high after Medicare named its HIV drug Biktarvy for price negotiations starting in 2028. Trading volume topped 10.5 million shares. CEO Daniel O’Day sold 115,640 shares last week under a pre-set plan. Gilead will report fourth-quarter and full-year results after markets close on Feb. 10.
28 January 2026
···
HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA stock jumps after earnings and a $10B buyback — what to watch before Wednesday’s open

HCA Healthcare shares surged 7.1% to $505.84 after the company raised its 2026 profit outlook and approved a new $10 billion share buyback. Fourth-quarter revenue rose 6.7% to $19.51 billion, with net income at $1.88 billion. Investors remain cautious as ACA exchange subsidies expire, potentially reducing patient volumes. The board also declared a $0.78 quarterly dividend, payable March 31.
28 January 2026
··
Coinbase stock in focus: Cantor’s $277 call clashes with UK ad ban as Fed looms

Coinbase stock in focus: Cantor’s $277 call clashes with UK ad ban as Fed looms

Coinbase shares fell 1.2% to $210.83 in after-hours trading Tuesday, despite Cantor Fitzgerald starting coverage with an Overweight rating and a $277 price target. Britain’s ad regulator banned a Coinbase campaign, saying it downplayed crypto risks; Coinbase disputed the ruling. Bitcoin rose 0.7% to $89,313, while Ether gained 2.6%. Coinbase’s next earnings report is pending.
28 January 2026
··
Rocket Lab stock jumps, but Neutron setback keeps investors on edge ahead of February results

Rocket Lab stock jumps, but Neutron setback keeps investors on edge ahead of February results

Rocket Lab shares rose 8% Tuesday before slipping after hours, following a recent Neutron Stage 1 tank rupture that cast uncertainty on the rocket’s launch timeline. The stock traded near $87, up from $80.48, after rebounding from a 9.5% drop Monday. Investors await the late-February earnings call for updates on the Neutron program. The company also secured an $816 million U.S. defense contract.
28 January 2026
···
Fatburger owner FAT Brands files Chapter 11 bankruptcy, pulling Twin Peaks parent Twin Hospitality into court

Fatburger owner FAT Brands files Chapter 11 bankruptcy, pulling Twin Peaks parent Twin Hospitality into court

FAT Brands and affiliate Twin Hospitality filed for Chapter 11 bankruptcy in Houston, citing $1.4 billion in debt and missed interest payments. Court documents show FAT Brands has just $2.1 million in cash. Shares of both companies fell by about a third in late trading. Restaurants, including Fatburger, Johnny Rockets, Twin Peaks, and Smokey Bones, will remain open.
28 January 2026
··
Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks stock dips as supply-chain snags and CEO jet policy land ahead of earnings

Starbucks shares fell 0.6% to $95.72 Tuesday ahead of its fiscal first-quarter earnings report set for Wednesday morning. CEO Brian Niccol is under scrutiny as supply-chain issues persist despite new technology and system upgrades. The company also removed the $250,000 cap on Niccol’s personal use of the corporate jet after a security review. Wall Street analysts adjusted price targets as investors focus on sales and margins.
28 January 2026
··
Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Carvana stock rises after Wells Fargo target hike, but options traders lean defensive

Carvana shares closed up 0.9% at $477.75 after volatile trading Tuesday. Wells Fargo raised its price target to $525, citing strong retail trends but flagged possible weather-related risks. Options trading showed a surge in put buying ahead of the Fed decision and Carvana’s Feb. 18 earnings. Implied volatility remained high, with puts outnumbering calls by nearly two to one.
28 January 2026
·
Constellation Energy stock closes higher as PJM data-center rule overhaul keeps power prices in focus

Constellation Energy stock closes higher as PJM data-center rule overhaul keeps power prices in focus

Constellation Energy closed up 1.2% at $288.76 Tuesday, after trading between $282.50 and $290.40. PJM Interconnection advanced a fast-track plan for data-center hookups and began talks on a government-backed “backstop” auction for new power capacity. Traders are watching natural-gas volatility and PJM/FERC policy moves. Constellation’s next earnings update is expected Feb. 17.
28 January 2026
··
Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health stock gets hit by Medicare rate surprise — what traders watch before earnings

Elevance Health shares fell 14.3% to $322.92 Tuesday after a Medicare Advantage rate proposal from CMS projected a net average payment increase of just 0.09%, far below Wall Street expectations. The move triggered a broader selloff in health insurer stocks. Investors are awaiting Elevance’s earnings report Wednesday for updates on pricing and costs. CMS will finalize policy milestones in late February and early April.
28 January 2026
··
Roper Technologies stock (ROP) slides after weak 2026 outlook puts Deltek back in focus

Roper Technologies stock (ROP) slides after weak 2026 outlook puts Deltek back in focus

Roper Technologies shares dropped 9.7% to $369.27 in after-hours trading Tuesday after the company issued a 2026 profit and revenue forecast below Wall Street estimates and warned of continued weak demand at its Deltek unit. Stifel downgraded the stock, citing ongoing Deltek softness. Roper reported Q4 revenue up 10% to $2.06 billion and adjusted EPS of $5.21. The company projected 2026 adjusted EPS of $21.30–$21.55.
28 January 2026
·
Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Johnson & Johnson stock climbs after fresh FDA Darzalex Faspro nod — what investors watch next

Johnson & Johnson shares rose 1.3% Tuesday after the FDA approved a Darzalex Faspro combination for newly diagnosed multiple myeloma patients ineligible for stem-cell transplants. The S&P 500 closed at a record high, while healthcare stocks broadly fell after a Medicare payment proposal. The U.S. also named 15 drugs for future Medicare price negotiations, increasing pressure on big pharma.
28 January 2026
···
1 … 249 250 251 252 253 … 764

Stock Market Today

  • Raymond James Cuts Stantec Target Price Amid Mixed Analyst Ratings
    April 29, 2026, 5:04 PM EDT. Raymond James Financial lowered its target price for Stantec (TSE:STN) from C$180 to C$165, signaling a cautious outlook despite a potential 34.68% upside. Other analysts showed varied sentiments: National Bank Financial and Scotiabank cut targets, while Royal Bank of Canada and Desjardins raised theirs. Stantec's stock traded down 0.4% at C$122.51 with moderate volume. The company posted Q4 earnings of C$0.82 per share on C$2.12 billion revenue. Stantec, specializing in engineering and consulting for infrastructure and sustainability, has a market cap near C$14 billion and holds a Moderate Buy consensus based on nine Buy and one Hold ratings.

Latest article

Nebius Stock Jumps as Meta’s AI Spending Reset Puts $27 Billion Deal in Focus

Nebius Stock Jumps as Meta’s AI Spending Reset Puts $27 Billion Deal in Focus

29 April 2026
Nebius Group N.V. shares rose 5.3% to $142.73 Wednesday as Meta Platforms raised its 2026 capital spending forecast by up to $10 billion, citing higher data center costs. Nebius has a contract to supply Meta with up to $27 billion in AI cloud capacity. Fourth-quarter 2025 revenue jumped 547% to $227.7 million, but the company reported a net loss of $249.6 million.
Phillips 66 Stock Jumps as Surprise Profit Shows Refining Margins Are Back in Focus

Phillips 66 Stock Jumps as Surprise Profit Shows Refining Margins Are Back in Focus

29 April 2026
Phillips 66 reported an adjusted first-quarter profit of $200 million, or 49 cents per share, beating analyst forecasts of a loss. Strong refining margins and 95% plant utilization offset $839 million in hedge-related losses. Shares rose over 6% after the results. The company also completed its acquisition of Lindsey Oil Refinery assets in the UK.
Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

Extreme Networks Stock Jumps as Q3 Earnings Beat Puts Cisco, HPE Rivals in Focus

29 April 2026
Extreme Networks shares surged 28% after reporting fiscal Q3 revenue of $316.9 million, up 11%, and non-GAAP earnings of 26 cents per share, both above estimates. The company forecast Q4 revenue of $330–$335 million, topping FactSet’s $326.9 million estimate. SaaS annual recurring revenue rose 28.6% to $236.4 million. Net income climbed to $10.6 million from $3.5 million a year earlier.
Go toTop